UTI

UTI INC. Decides to Issue 2.5 Billion KRW 7th Convertible Bond... Premium Conversion Price but Significant Accumulated Dilution Risk from Existing CBs


  • UTI INC. has decided to issue the 7th series unregistered private convertible bond worth 2.5 billion KRW to raise operating funds, with a conversion price of 4,795 KRW, a premium of about 21% over the current stock price of 3,950 KRW.
  • The new CB adds a dilution of 2.63% of outstanding shares, but combined with existing CBs totaling approximately 94.5 billion KRW, the total potential dilution reaches 22.54%. The conversion price can be adjusted downward to as low as 3,357 KRW, increasing dilution risk if the stock price falls.
  • Proceeds will be used for operating funds for foldable mass production. The coupon rate is 1.0%, a low cost, but the yield to maturity is 3.0%, and investors hold a put option for early redemption after 24 months.
  • The counterparty is Seven Bridge Unique Glass New Technology Investment Association 2, unrelated to the largest shareholder, and tag-along rights are granted.
  • [AI Summary]UTI INC. secured short-term operating funds through this CB issuance, but together with existing large-scale CBs, the dilution burden on shareholder value is significant. Although the conversion price is set at a premium, anti-dilution adjustments could accelerate dilution if the stock falls, requiring close monitoring of stock price and adjustment triggers.

KOSDAQ Filing Information


  • Report On Major Events (Decision On Issuance Of Convertible Bonds)
  • Company: UTI (179900)
  • Submission: UTI INC.

  • Shares: 19,790,412
  • Price: 3,950 KRW
  • Market Cap: 78.2 B KRW